Every lyophilized research peptide requires reconstitution before use, and the choice of reconstitution solvent affects stability, compatibility, and multi-dose usability in ways that directly impact data quality. Bacteriostatic water (BAC water) is the standard reconstitution solvent for the majority of research peptides — not because it is the only option, but because its specific formulation addresses the most common practical challenges in a peptide research workflow. Understanding what makes it the right choice — and the edge cases where it isn’t — is part of running a consistent lab.
What Bacteriostatic Water Is
Bacteriostatic water for injection is sterile water preserved with 0.9% benzyl alcohol (w/v). The benzyl alcohol concentration is precisely chosen: sufficient to inhibit bacterial growth across multiple vial entries while remaining below concentrations that would meaningfully affect most peptide compounds or cellular assays at standard dilutions.
The “bacteriostatic” qualifier means the benzyl alcohol inhibits bacterial replication rather than killing bacteria outright — a distinction relevant for storage protocols. A contaminated vial of bacteriostatic water will not show visible bacterial growth the way an unpreserved vial might, but it is not sterile in the sense of being entirely free of microbial life if contaminated. Proper aseptic technique at each vial entry remains essential; the preservative is not a substitute for technique.
Bacteriostatic Water vs. Sterile Water vs. Saline
These three solvents are not interchangeable. The differences matter for research protocol design.
Sterile water has no preservative. Once the septum is punctured, the remaining volume is exposed to potential contamination with each subsequent entry. USP guidelines classify sterile water vials as single-use for this reason. For protocols requiring a single preparation from each vial, sterile water is acceptable. For multi-dose protocols — where the same vial will be accessed multiple times over days or weeks — the contamination risk with sterile water makes it a poor choice.
Saline (0.9% NaCl) introduces sodium ions at a concentration that can affect the solubility of certain peptides and alter the ionic environment of cell culture assays. It is the preferred diluent for some injectable formulations, but for most peptide research protocols, the ionic content adds variables that bacteriostatic water avoids. Saline also lacks preservative, making it similarly single-use in practice.
Bacteriostatic water combines sterility, preservative stability across multiple entries, and a relatively neutral ionic environment. It is the most broadly compatible reconstitution solvent for lyophilized research peptides and is specified in the majority of published peptide research protocols.
pH and Peptide Compatibility
Bacteriostatic water maintains a pH of approximately 5.0-7.0 — slightly acidic to neutral. Most research peptides dissolve readily and maintain stability in this range. Some peptides with extreme isoelectric points (very high or very low pI) may require pH adjustment or a different buffer system for optimal solubility, but these cases are exceptions rather than the rule.
Specific compatibility notes for commonly studied compounds: BPC-157 dissolves readily and maintains stability in bacteriostatic water with no additives required. TB-500, GHK-Cu, Ipamorelin, CJC-1295 with DAC, Semax, and Epithalon all behave similarly. Melanotan II and PT-141 are slightly more sensitive to light than other compounds and should have reconstituted solutions protected from prolonged light exposure. NAD+ is water-soluble but not a peptide — it dissolves readily in bacteriostatic water but is better stored as dry powder given its shorter solution stability.
Acetic acid is sometimes specified for peptides with very low solubility in neutral aqueous solution. If your COA or published protocol specifies 10% acetic acid rather than plain bacteriostatic water, this should be followed. Mixing acetic acid into bacteriostatic water at the appropriate concentration is more commonly done by experienced researchers than purchasing pre-acidified BAC water, which is not a standard commercial product.
Calculating Reconstitution Volumes
The most common error in peptide reconstitution is incorrect volume calculation. The math is straightforward, but the consequences of a concentration error compound across every downstream calculation in the protocol.
The formula: volume of BAC water (mL) = mass of peptide (mg) ÷ target concentration (mg/mL)
Examples: A 5mg BPC-157 vial at target concentration 2mg/mL requires 2.5mL of bacteriostatic water. A 10mg TB-500 vial at target concentration 1mg/mL requires 10mL. A 100mg GHK-Cu vial at target concentration 10mg/mL requires 10mL.
The choice of target concentration depends on the dosing volume your protocol requires. Protocols using small injection volumes (50-100μL) work better with higher concentrations; those using larger volumes can use lower concentrations. The reconstitution calculator at corevionrx.com/calculator handles this automatically — enter the vial size and target concentration, and it returns the exact BAC water volume to add.
Reconstitution Technique Step by Step
Technique at reconstitution affects peptide integrity. Mechanical disruption during reconstitution — particularly foaming from vigorous mixing — can cause aggregation in some peptides that is not fully reversible.
- Allow the lyophilized vial to reach room temperature before opening or reconstituting. Cold vials condensate when opened, introducing moisture that can degrade the powder before reconstitution is complete.
- Wipe the rubber septum of both the BAC water vial and the peptide vial with a fresh alcohol swab. Allow to dry completely before proceeding.
- Draw the calculated volume of BAC water into a clean syringe. For volumes above 2mL, use a larger syringe to maintain control.
- Insert the needle into the peptide vial and direct the stream of water slowly down the inner wall of the vial — not directly onto the lyophilized powder. Directing water onto the powder causes turbulence that can mechanically stress the peptide.
- Once all water is added, remove the needle and gently swirl the vial in a circular motion. Do not shake. The solution should become clear. Cloudiness may indicate incomplete dissolution (swirl more) or aggregation (check reconstitution conditions and peptide quality).
- If the solution does not clear after several minutes of swirling, check that the calculated volume was correct and that the peptide and water are fully mixed. Some peptides (particularly those at high concentrations or with lower intrinsic solubility) require 5-10 minutes of occasional swirling to fully dissolve.
Multi-Dose Storage After Reconstitution
Reconstituted peptides stored in bacteriostatic water at 2–8°C maintain usability for approximately 28 days in most cases. The benzyl alcohol preservative inhibits microbial growth across multiple needle entries during this period. However, the peptide itself may degrade over this timeframe regardless of sterility — temperature, light exposure, and the number of freeze-thaw cycles (if applicable) all affect the rate of degradation.
Best practice for multi-dose use: minimize the number of vial entries. Use a dedicated syringe for drawing doses rather than reusing the same syringe across multiple time points. Do not freeze reconstituted solutions unless the peptide’s stability data specifically supports freeze-thaw recovery for that compound — most peptides perform better stored at refrigerator temperature than cycled between frozen and thawed states.
Storage of Unopened BAC Water Vials
Bacteriostatic water vials should be stored at room temperature (15–30°C) or refrigerated (2–8°C) before first use. Freezing is unnecessary and may stress the rubber stopper. Once opened — defined as first needle puncture through the septum — the vial should be used within 28 days, consistent with USP multi-dose vial guidelines. Label the vial with the opening date. Inspect visually before each use — discard if cloudiness, particulate matter, or color change is observed.
Key Reference Standards
- United States Pharmacopeia (USP) General Chapter <1> Injections and Implanted Drug Products. Specifies multi-dose container requirements and benzyl alcohol concentration standards for bacteriostatic preparations.
- United States Pharmacopeia (USP) General Chapter <71> Sterility Tests. Establishes sterility standards applicable to bacteriostatic water production.
- FDA Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing — Current Good Manufacturing Practice. Relevant for understanding production standards applicable to BAC water sourced for research use.
For related peptide preparation guides, see the How to Reconstitute Research Peptides guide and Peptide Storage Guide.
Source Bacteriostatic Water for Research
Bacteriostatic Water Research Overview →
Order Bacteriostatic Water from CoreVionRX →
For more on purity verification, COA reading, reconstitution, and sourcing standards: Research Peptide FAQs · CoreVionRX testing standards
Related Research Guides